Yield10 Bioscience Overview
Latest ROE for Yield10 Bioscience: 203.62% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow203.62%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
As of the most recent data, YTEN shows a ROE of 203.62%. That is above the Consumer Discretionary sector average of 23.23%. Scroll down for historical charts and peer comparison views.
The Consumer Discretionary sector average ROE is about 23.23%. Yield10 Bioscience is at 203.62%, which is higher that average. That is roughly 776.6% above the sector mean. Use the comparison chart on this page to see how YTEN stacks up against individual peers as well.
Check the historical chart to see whether YTEN's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Yield10 Bioscience with peers to see if the move is company-specific or sector-wide.
Besides this return on equity page, Stockcircle has Yield10 Bioscience's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 203.62%) with ownership activity and broader fundamentals.
The Consumer Discretionary average ROE is about 23.23%, while YTEN is at 203.62%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
